Patent Assignment
Reel/Frame 047269/0745
Change of Name
Recorded: 2018-10-18
Pages: 4
Assignor
LUC THERAPEUTICS, INC.
Executed: 2017-04-06
Assignee
CADENT THERAPEUTICS, INC.
400 TECHNOLOGY SQUARE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
N-Arylmethyl Sulfonamide Negative Modulators of NR2A
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 18, 2017
From: ANDERSON, DAVID R; VOLKMANN, ROBERT A
To: LUC THERAPEUTICS
Reel/Frame 043894/0343 →
Corrective Assignment to Correct the Name of Assignee Previously Recorded on Reel 043894 Frame 0343. Assignor(S) Hereby Confirms the Assignment to Luc Therapeutics, Inc..
Mar 12, 2018
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.
To: LUC THERAPEUTICS, INC.
Reel/Frame 046812/0025 →
Assignment of Assignor's Interest
Aug 24, 2023
From: CADENT THERAPEUTICS, INC.
To: NOVARTIS AG
Reel/Frame 064691/0310 →